This bill adds nurse anesthetists and dietitian nutritionists to Nebraska's Rural Health Systems and Professional Incentive Act. It expands eligibility for student loans and loan repayment programs to include these professions, allowing them to qualify for financial assistance if they practice in designated health shortage areas. Specifically, nurse anesthetists and dietitian nutritionists become eligible for up to $15,000 annually in loan repayment (capped at $45,000 total) under the same terms as other qualifying healthcare providers like nurse practitioners and physical therapists. The bill amends existing statutes to formally include these professions in program eligibility and shortage area designations.
LB 382 redirects $2 million annually from Nebraska's Medicaid Managed Care Excess Profit Fund to reimburse the state's eight Area Agencies on Aging (AAAs) for eligible activities and services defined under existing law. The bill specifically appropriates these funds for fiscal years 2025-26 and 2026-27, with an equal share distributed to each AAA. This ensures AAAs receive reimbursement for costs related to services supporting older Nebraskans, such as transportation, meals, and home care, as outlined in section 81-2222. The bill amends existing funding mechanisms to prioritize these reimbursements while maintaining current eligibility criteria.
LB 382A appropriates $2 million from the Medicaid Managed Care Excess Profit Fund for each of the 2025-26 and 2026-27 fiscal years to the Department of Health and Human Services. The funds are designated for Program 571 to support the implementation of Legislative Bill 382. The bill specifies that the money must be used solely for state aid and cannot cover salaries or per diems for state employees.
Nebraska's LB 641 amends Medicaid estate recovery rules to protect certain family members' homes from being seized to repay medical assistance costs after a recipient's death. The bill specifically exempts homes from recovery if a sibling lived there continuously for one year before the recipient's institutionalization or if an adult child provided care while living in the home for two years prior to institutionalization. To qualify for these exemptions, a physician's written attestation must verify the care provided that delayed institutionalization. The changes clarify which family members retain home ownership protections and require specific documentation to avoid estate recovery claims.
Nebraska's LB 414 establishes a suicide mortality review team within the Department of Veterans' Affairs to address veteran suicides. The team, made up of VA staff, mental health professionals, law enforcement, and veteran advocates, will collect data on all veteran suicide deaths in Nebraska, analyze causes, and develop prevention protocols for agencies like hospitals and law enforcement. It requires an annual report by April 1st starting in 2026, detailing each reviewed case (including age, location, and contributing factors) and recommendations to reduce preventable suicides. The bill directly affects veterans who died by suicide and aims to improve data-driven prevention strategies through coordinated reviews.
LB 457 requires Nebraska school districts and licensed child care facilities to adopt written policies for managing anaphylaxis (severe allergic reactions) by July 1, 2026. These policies must include emergency protocols, individualized care plans for children with allergies, and strategies to reduce allergen exposure, based on model guidelines developed by the Health and Human Services Department. The bill also limits out-of-pocket insurance costs for epinephrine injectors to $50 annually for covered individuals, effective January 1, 2026. It directly affects schools, child care programs, and insured individuals needing emergency allergy treatment.
LB 41A is an appropriation bill that allocates specific state and federal funds to the Nebraska Department of Health and Human Services for two Medicaid-related programs (344 and 348) to support implementation of Legislative Bill 41. It provides $28,021 (state and federal combined) for Program 344 and $155,579 for Program 348 in fiscal year 2025-26, with similar amounts for 2026-27. The funds must be used exclusively for their designated program purposes and cannot cover state employee salaries. This bill directly affects the Department of Health and Human Services and the Medicaid programs it administers.
This Nebraska bill updates requirements for blood tests during pregnancy. It mandates that healthcare providers offer voluntary syphilis tests at the first prenatal visit, third trimester, and delivery, and voluntary HIV tests during pregnancy (with written refusal allowed). Providers must clearly inform patients about these tests and their right to decline. The bill also ensures Medicaid-covered individuals will have syphilis test costs covered by Medicaid funds, and test results must be reported to health officials without appearing on birth certificates.
LB 22A is an appropriation bill that allocates specific funds to support Legislative Bill 22. It provides $380,628 from the Medicaid Managed Care Excess Profit Fund and $694,972 in federal funds for fiscal year 2025-26, and $774,002 plus $1,377,198 for 2026-27, all to the Department of Health and Human Services' Program 348. These funds are designated exclusively to carry out the provisions of LB 22, with no use permitted for state employee salaries or per diems. The bill directly affects the state's Medicaid program administration by providing targeted financial resources for its implementation.
Nebraska's LB 168 (signed April 9, 2025) adopts the 340B Contract Pharmacy Protection Act to protect access to federally discounted drugs. It prohibits drug manufacturers from restricting 340B drug deliveries to authorized locations (like contract pharmacies) or demanding extra data (such as patient records) beyond federal requirements. The law directly affects safety-net hospitals, clinics, and other 340B entities that rely on discounted drugs, as well as drug manufacturers and distributors. It ensures these providers can continue using 340B discounts without unnecessary barriers imposed by manufacturers.
